FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Inderal LA (propranolol hydrochloride) filed by ANI Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Cardiac Arrhythmias
• Essential Tremor
• Hypertension
• Migraine

Drugs mentioned

• INDERAL LA (Propranolol hydrochloride)

Snippet

SUPPL AP for INDERAL LA (PROPRANOLOL HYDROCHLORIDE)